UnitedHealth Group Incorporated (NYSE:UNH) Position Raised by IMS Capital Management

IMS Capital Management increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 1.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,759 shares of the healthcare conglomerate’s stock after purchasing an additional 32 shares during the period. UnitedHealth Group accounts for about 0.9% of IMS Capital Management’s investment portfolio, making the stock its 28th largest holding. IMS Capital Management’s holdings in UnitedHealth Group were worth $1,417,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Norges Bank bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $4,478,185,000. Arrowstreet Capital Limited Partnership increased its holdings in shares of UnitedHealth Group by 1,682.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after buying an additional 2,540,538 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of UnitedHealth Group by 60.4% in the first quarter. The Manufacturers Life Insurance Company now owns 5,009,284 shares of the healthcare conglomerate’s stock valued at $2,580,442,000 after buying an additional 1,886,128 shares in the last quarter. Capital Research Global Investors increased its holdings in shares of UnitedHealth Group by 8.3% in the first quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock valued at $9,829,129,000 after buying an additional 1,482,338 shares in the last quarter. Finally, Invesco Ltd. increased its holdings in shares of UnitedHealth Group by 28.3% in the first quarter. Invesco Ltd. now owns 6,018,008 shares of the healthcare conglomerate’s stock valued at $3,069,002,000 after buying an additional 1,328,237 shares in the last quarter. Institutional investors own 87.25% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction dated Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction dated Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Stephen J. Hemsley sold 99,312 shares of the company’s stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the sale, the director now directly owns 787,372 shares in the company, valued at $420,669,238.44. The disclosure for this sale can be found here. Insiders have sold a total of 139,051 shares of company stock valued at $74,450,958 over the last quarter. 0.40% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 1.1 %

Shares of UNH opened at $517.46 on Friday. The company has a 50-day simple moving average of $530.11 and a 200-day simple moving average of $512.45. The firm has a market capitalization of $484.02 billion, a P/E ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.77 and a current ratio of 0.77. UnitedHealth Group Incorporated has a 52 week low of $383.12 and a 52 week high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. The business had revenue of $80.33 billion during the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The firm’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.70 earnings per share. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Monday, September 12th were paid a $1.65 dividend. The ex-dividend date of this dividend was Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a yield of 1.28%. UnitedHealth Group’s payout ratio is currently 34.46%.

Analysts Set New Price Targets

UNH has been the topic of several research reports. Argus upped their price target on UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a report on Monday, July 25th. BMO Capital Markets lifted their price objective on shares of UnitedHealth Group from $600.00 to $610.00 in a research report on Wednesday, July 20th. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. UBS Group lifted their price objective on shares of UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research report on Thursday, July 21st. Finally, Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Three research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $586.40.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.